Press Releases

06-04 Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 BU
06-02 Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry BU
06-02 Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis AQ
06-01 Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology BU
05-27 Bruker Corporation - Champalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI AQ
05-26 Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI BU
05-08 Bruker : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) PU
05-06 Bruker : Q1 2026 Earnings Webcast (Presentation) PU
05-06 Bruker: Q1 Earnings Snapshot AQ
05-06 Bruker Reports First Quarter 2026 Financial Results BU
04-27 Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast AQ
04-24 Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast BU
04-20 Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 AQ
04-20 Bruker Launches MyGenius PRO(R) High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 AQ
04-20 Bruker Expands Industry-Leading MALDI Biotyper(R) and IR Biotyper(R) Workflows for Microbial Identification and Outbreak Management AQ
04-17 Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 BU
04-17 Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 BU
04-17 Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management BU
04-13 Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 BU
04-10 Bruker : 2025 Annual Report of 2025 PU
04-07 Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research BU
04-01 Bruker Announces Appointment of Thierry Bernard to its Board of Directors BU
03-31 PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge BU
03-23 Bruker : Showcases Analytical and Automation Innovations for Applied, Biopharma, Industrial and Academic Markets at Analytica 2026 PU
02-25 Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR BU
No results match your criteria